Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lamin B1 is a type V intermediate filament protein and a member of the lamin family that forms the nuclear lamina, a network underlying the inner nuclear membrane in metazoan cells. It serves crucial roles in maintaining nuclear shape, mechanical stability, and structural support, organizes chromatin and regulates genome function and gene expression, and is essential for proper cell cycle progression, DNA replication, and DNA repair. Lamin B1 is especially important for brain development and function: duplication of the LMNB1 gene causes autosomal dominant adult-onset demyelinating leukodystrophy, while deficiency leads to developmental deficits, including neural tube defects and abnormal neuronal dendrite morphology. Lamin B1 is anchored to the nuclear envelope and is permanently farnesylated, distinguishing it from A-type lamins, and it interacts with chromatin regions called lamin-associated domains (LADs) associated with gene repression. Altered Lamin B1 levels serve as biomarkers for cellular senescence, aging, and certain neuropathological states. Although it is critical for cell viability and genome organization, it is not currently considered a direct pharmacological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lamin B1 (LMNB1).